All Relations between Neurodegenerative Diseases and adam17
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| Vitoria Mattos Pereira, Suyasha Pradhanang, Jonathan F Prather, Sreejayan Nai. Role of Metalloproteinases in Diabetes-associated Mild Cognitive Impairment. Current neuropharmacology. 2024-07-04. PMID:38963109. | recent research has provided novel insights into the role of adam17 in diabetes and neurodegenerative diseases. | 2024-07-04 | 2024-07-10 | Not clear |
| Yanna Tian, Katie Anne Fopiano, Vadym Buncha, Liwei Lang, Hayden A Suggs, Rongrong Wang, R Daniel Rudic, Jessica A Filosa, Zsolt Bag. The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer's disease. Frontiers in molecular neuroscience. vol 16. 2023-03-20. PMID:36937050. | the role of vascular adam17 in neurodegenerative diseases remains poorly understood. | 2023-03-20 | 2023-08-14 | mouse |
| Rohan Umesh Parekh, Srinivas Sriramul. Activation of Kinin B1R Upregulates ADAM17 and Results in ACE2 Shedding in Neurons. International journal of molecular sciences. vol 22. issue 1. 2021-04-01. PMID:33375653. | alterations in ace2 gene and protein expression, and activity mediated by a disintegrin and metalloprotease 17 (adam17), a member of the "a disintegrin and metalloprotease" (adam) family are implicated in several cardiovascular and neurodegenerative diseases. | 2021-04-01 | 2023-08-13 | mouse |